Exchange: NASDAQ·Updated 07:30 PM EDT
KYTX logo

KYTX Kyverna Therapeutics Inc.

$8.25
$0.10
(1.20%)
Today
Closed $8.25
$0.01
(0.12%)
After Hours
Reported EarningsAug 11
Mkt Cap$510.21M
Vol500,823.00

About KYTX

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
74

Bullish Sentiment

How do you feel about KYTX?

Advertisement|Remove ads.